Synonyms: RP 57669 | RP-57669 | RP57669 | Synercid® (dalfopristin + quinupristin)
quinupristin is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Quinupristin is a semi-synthetic derivative of streptogramin B. It inhibits the late stage of protein synthesis by binding to the bacterial 50S ribosomal subunit.
|
|
No information available. |
Summary of Clinical Use |
Quinupristin is intravenously administered in fixed combination with dalfopristin to treat severe bacterial infections due to susceptible organisms including methicillin resistant Staphylococcus aureus (MRSA) or Streptococcus pyogenes. |
External links |
For extended ADME data see the following: Drugs.com |